Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Application of induced pluripotent stem cell technology for the investigation of hematological disorders.

Journal article

Dolatshad H. et al, (2019), Adv Biol Regul, 71, 19 - 33

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.

Journal article

Naeimi Kararoudi M. et al, (2018), J Vis Exp

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.

Journal article

Yip BH. et al, (2017), J Clin Invest, 127, 2206 - 2221

Application of genome editing technologies to the study and treatment of hematological disease.

Journal article

Pellagatti A. et al, (2016), Adv Biol Regul, 60, 122 - 134

Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.

Journal article

Yip BH. et al, (2016), Curr Pharm Des, 22, 2333 - 2344

A versatile transgenic allele for mouse overexpression studies.

Journal article

Dolatshad H. et al, (2015), Mamm Genome, 26, 598 - 608

A versatile transgenic allele for mouse overexpression studies

Journal article

Dolatshad H. et al, (2015), Mammalian Genome, 26, 598 - 608

Application of CRISPR/Cas9 genome editing to the study and treatment of disease.

Journal article

Pellagatti A. et al, (2015), Arch Toxicol, 89, 1023 - 1034

CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING

Conference paper

Valletta S. et al, (2015), HAEMATOLOGICA, 100, 169 - 169

Embryonic development of circadian oscillations in the mouse hypothalamus.

Journal article

Wreschnig D. et al, (2014), J Biol Rhythms, 29, 299 - 310

Load More